首页|期刊导航|Infectious Medicine|Long-term protective efficacy of the Escherichia coli-produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18-45 years:A 9-year follow-up study
Infectious Medicine2025,Vol.4Issue(1):P.37-42,6.DOI:10.1016/j.imj.2025.100164
Long-term protective efficacy of the Escherichia coli-produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18-45 years:A 9-year follow-up study
摘要
关键词
Human papilloma virus/Human papilloma virus infection/Human papilloma virus vaccine/Long-term follow-up/Protective efficacy分类
医药卫生引用本文复制引用
Xinhua Jia,Shangying Hu,Xuefeng Kuang,Youlin Qiao..Long-term protective efficacy of the Escherichia coli-produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18-45 years:A 9-year follow-up study[J].Infectious Medicine,2025,4(1):P.37-42,6.基金项目
supported by the CAMS Innovation Fund for Medical Sciences(Grant Number:CAMS 2021-I2M-1-004) (Grant Number:CAMS 2021-I2M-1-004)
support from the Tencent Sustainable Social Value Inclusive Health Lab and the ChongQing Tencent Sustainable Development Foundation through the“Comprehensive Prevention and Control Demonstration Project for Eliminating Cervical Cancer and Breast Cancer in Low Health Resource Areas of China”(Project Number:SD20240904145730). (Project Number:SD20240904145730)